FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to producing representative populations of hematopoietic cells and a kit for preparing them. Method involves culturing hematopoietic cells on magnetic stromal layers obtained by incubating stromal cells with magnetic nanoparticles or magnetic liposomes with subsequent treatment of mitomycin C cells or irradiation with X-ray or gamma radiation to stop their division, when collecting hematopoietic cells, culture is dissociated by treatment with trypsin, collagenase, or another proteolytic enzyme, or by intensive mixing of the culture, and purification of cell preparations is carried out by removing magnetic stroma on magnet.
EFFECT: invention allows increasing the total number of hematopoietic cells collected after culturing.
5 cl, 10 dwg, 2 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING ASSOCIATES OF HEMATOPOIETIC AND STROMAL PROGENITOR CELLS CAPABLE OF SUPPRESSING ACTIVATION AND PROLIFERATION OF ALLOGENIC LYMPHOCYTES | 2019 |
|
RU2722669C1 |
METHOD FOR OBTAINING OF MSC-ASSOCIATED NON-DIFFERENTIATED HEMOPOIETIC PRECURSOR CELLS WITH CD34+/CD133+ PHENOTYPE | 2016 |
|
RU2628092C1 |
METHOD FOR EXPANSION OF CD34+ HEMATOPOIETIC CELLS | 2011 |
|
RU2469086C1 |
METHOD FOR CORD BLOOD MONONUCLEAR CELLS (cbMNC) EXPANSION ex vivo IN PRESENCE OF MULTIPOTENT MESENCHYMAL STROMAL CELLS (MMSCS) | 2013 |
|
RU2525143C1 |
METHOD OF REPRODUCING HUMAN MESENCHIMAL STROMAL CELL CULTURES RECOVERED FROM LIPOASPIRATE | 2007 |
|
RU2351649C1 |
CELL PRODUCT FOR TREATING AND CORRECTING HEPATIC IMPAIRMENT | 2012 |
|
RU2510833C1 |
METHOD FOR PRODUCING AND MAINTAINING MESENCHYMAL STEM CELLS FROM MAMMALIAN BONE MATERIAL | 2023 |
|
RU2821926C1 |
Ex vivo METHOD TO INCREASE QUALITY OF PRECURSOR CELLS FROM AGE DONORS | 2012 |
|
RU2484133C1 |
METHOD OF USING 4-((5,10-DIMETHYL-6-OXO-6,10-DIHYDRO-5H-PYRIMIDO[5,4-b]THIENO[3,2-e][1,4]DIAZEPIN-2-YL)AMINO)BENZENESULFONAMIDE (XMU-MP-1) TO INHIBIT GROWTH OF BURKITT'S LYMPHOMA CELLS | 2023 |
|
RU2814013C1 |
FRACTION OF DNA-HYDROLYSE SECRETORY IMMUNOGLOBULINS OF CLASS A, WITH SELECTIVE APOPTOTIC ACTIVITY IN RELATION TO HUMAN CANCER CELLS | 2015 |
|
RU2605321C1 |
Authors
Dates
2019-05-21—Published
2016-12-12—Filed